mRNA |
BRD-K71935468 |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
2e-06 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
5e-05 |
mRNA |
CGP-082996 |
GDSC1000 |
pan-cancer |
AAC |
-0.21 |
0.0002 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0006 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0006 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0008 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0009 |
mRNA |
BRD-K94991378 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.001 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |